Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kedrion IVIG 10% in Primary Immunodeficiency Disease
NCT03961009Phase 3Completed
- Sponsor
- Kedrion Biopharma
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of immune globulin intravenous (human) in primary immunodeficiency disease (PID), sponsored by Kedrion Biopharma. Started Apr 2019; status: completed.
02
Drugs
immune globulin intravenous (human)
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT03961009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961009.